Topics to be discussed:

1. Radiolabelled PSMA PET-CT in prostate cancer: evidence based clinical applications 
2. Normal variants, artefacts, and pitfalls in Radiolabelled PSMA PET-CT imaging
3. Structured reporting of Radiolabelled PSMA PET-CT: how much is too much
4. Radiolabelled PSMA PET-CT in assessment of treatment response: is there a right way?
5. Radioguided biopsy in prostate cancer and radioguided surgery 
6. Radiolabelled PSMA PET-CT in non-prostate cancers 
7. Evidence based summary of Radiolabelled PSMA PET-CT in prostate cancer and non-prostate cancers and Radiolabelled PSMA therapy
8. Cut the clutter: open discussion on Radiolabelled PSMA PET-CT imaging and therapy
9. Developing a Radiolabelled PSMA therapy theragnostic unit
10. Patient selection criteria for Radiolabelled PSMA therapy
11. Radiolabelled PSMA therapy: technique, protocols, and management of side effects
12. Evidence based Summary of Radiolabelled therapy in prostate cancer
13. Radiation protection scenarios: case based discussion

View programme

Target audience: 

Nuclear Medicine Physicians, Urologists, Oncologists, Physicists, Technologists, Nurses, and nuclear medicine/Radiology/ Oncology residents.